This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, R. N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2005, p. 925-927, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.925-927.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Quality Control Guidelines for Testing Gram-Negative Control Strains with Polymyxin B and Colistin (Polymyxin E) by Standardized Methods

Ronald N. Jones,1,2* Tamara R. Anderegg,1,3 Jana M. Swenson,3 and The Quality Control Working Group{dagger}

The JONES Group/JMI Laboratories, North Liberty, Iowa,1 Tufts University School of Medicine, Boston, Massachusetts,2 Centers for Disease Control and Prevention, Atlanta, Georgia3

Received 7 September 2004/ Returned for modification 19 October 2004/ Accepted 22 October 2004

An eight-laboratory study addressed the urgent need for quality control (QC) ranges for susceptibility determination when testing colistin (polymyxin E) and polymyxin B, two polycationic peptide antimicrobial agents, against multidrug-resistant gram-negative bacilli. For Escherichia coli ATCC 25922l, the QC ranges were as follows: for colistin, 0.25 to 1 µg/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 µg/ml (13 to 19 mm). For Pseudomonas aeruginosa ATCC 27853, the QC ranges were as follows: for colistin, 0.25 to 2 µg/ml (11 to 17 mm), and for polymyxin B, 0.25 to 2 µg/ml (14 to 18 mm). More than 97% of all reported QC results were within these proposed ranges.

* Corresponding author. Mailing address: The JONES Group/JMI Laboratories, Inc., 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317. Phone: (319) 665-3370. Fax: (319) 665-3371. E-mail: ronald-jones{at}jmilabs.com.

{dagger} Members of the Quality Control Working Group are listed in Acknowledgments.

Journal of Clinical Microbiology, February 2005, p. 925-927, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.925-927.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Savini, V., Catavitello, C., Talia, M., Balbinot, A., Febbo, F., Pompilio, A., Di Bonaventura, G., Piccolomini, R., D'Antonio, D. (2009). Isolation of colistin-resistant Hafnia alvei. J Med Microbiol 58: 278-280 [Full Text]  
  • Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
  • Zavascki, A. P., Goldani, L. Z., Li, J., Nation, R. L. (2007). Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 60: 1206-1215 [Abstract] [Full Text]  
  • Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., van Keulen, P. H. J. (2007). Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains. Antimicrob. Agents Chemother. 51: 3726-3730 [Abstract] [Full Text]  
  • Quinteira, S., Grosso, F., Ramos, H., Peixe, L. (2007). Molecular Epidemiology of Imipenem-Resistant Acinetobacter haemolyticus and Acinetobacter baumannii Isolates Carrying Plasmid-Mediated OXA-40 from a Portuguese Hospital. Antimicrob. Agents Chemother. 51: 3465-3466 [Full Text]  
  • Turnidge, J., Bordash, G. (2007). Statistical Methods for Establishing Quality Control Ranges for Antibacterial Agents in Clinical and Laboratory Standards Institute Susceptibility Testing. Antimicrob. Agents Chemother. 51: 2483-2488 [Abstract] [Full Text]  
  • Sekiguchi, J.-I., Asagi, T., Miyoshi-Akiyama, T., Kasai, A., Mizuguchi, Y., Araake, M., Fujino, T., Kikuchi, H., Sasaki, S., Watari, H., Kojima, T., Miki, H., Kanemitsu, K., Kunishima, H., Kikuchi, Y., Kaku, M., Yoshikura, H., Kuratsuji, T., Kirikae, T. (2007). Outbreaks of Multidrug-Resistant Pseudomonas aeruginosa in Community Hospitals in Japan. J. Clin. Microbiol. 45: 979-989 [Abstract] [Full Text]  
  • Tan, T. Y., Ng, L. S. Y. (2006). Comparison of three standardized disc susceptibility testing methods for colistin. J Antimicrob Chemother 58: 864-867 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»